Company: ARMP
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001104659-25-040273
Chunk: 54

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 54
---
 ​ | ​ |
| Compensation Actually Paid (as calculated)                                                                                        | ​ | ​ | ​         | $ |   -347,905 | ​ | ​ | ​ | ​                    | $ |  278,524 | ​ | ​ |

35

| ​                                                                                                                                  
 Adjustments:                                                                                                                       | ​ 
 ​ | ​ 
 ​ | FY 2023 
 PEOBirx |   |           |   | ​ | ​ | PEOVarnum |   |          |   | ​ | ​ | Other NEOsAverage(c) |   |         |   | ​ 
 ​ |
|:-----------------------------------------------------------------------------------------------------------------------------------|:--|:--|:--------|:--|----------:|:--|:--|:--|:----------|:--|---------:|:--|:--|:--|:---------------------|:--|--------:|:--|:--|
| Total from Summary Compensation Table                                                                                              | ​ | ​ | ​       | $ | 1,133,931 | ​ | ​ | ​ | ​         | $ |  634,140 | ​ | ​ | ​ | ​                    | $ | 316,267 | ​ | ​ |
| Adjustments for stock and options awards                                                                                           | ​ | ​ | ​       | ​ |         ​ | ​ | ​ | ​ | ​         | ​ |        ​ | ​ | ​ | ​ | ​                    | ​ |       ​ | ​ | ​ |
| Deduct: SCT Amounts(a)                                                                                                             | ​ | ​ | ​       | ​ |  -875,477 | ​ | ​ | ​ | ​         | ​ |        — | ​ | ​ | ​ | ​                    | ​ | -33,087 | ​ | ​ |
| Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year﻿(b)                        | ​ | ​ | ​       | ​ | 1,162,650 | ​ | ​ | ​ | ​         | ​ |        — | ​ | ​ | ​ | ​                    | ​ |  43,032 | ​ | ​ |
| Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year﻿(b)  | ​ | ​ | ​       | ​ |         — | ​ | ​ | ​ | ​         | ​ |    5,713 | ​ |